Marbocyl P 5 mg Tablet

Երկիր: Միացյալ Թագավորություն

Լեզու: անգլերեն

Աղբյուրը: VMD (Veterinary Medicines Directorate)

Ակտիվ բաղադրիչ:

Marbofloxacin

Հասանելի է:

Vetoquinol UK Ltd

ATC կոդը:

QJ01MA93

INN (Միջազգային անվանումը):

Marbofloxacin

Դեղագործական ձեւ:

Tablet

Ռեկվիզորի տեսակը:

POM-V - Prescription Only Medicine – Veterinarian

Թերապեւտիկ խումբ:

Cats, Dogs

Թերապեւտիկ տարածք:

Antimicrobial

Լիազորման կարգավիճակը:

Authorized

Հաստատման ամսաթիվը:

2003-06-20

Ապրանքի հատկությունները

Revised: September 2023
AN: 00690/2023
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
MARBOCYL P 5 mg tablet
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Ingredient Marbofloxacin 5mg per tablet
FOR A FULL LIST OF EXCIPIENTS, SEE SECTION 6.1
3.
PHARMACEUTICAL FORM
Beige brown spotted round tablet
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
DOGS AND CATS
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In dogs
Marbofloxacin is indicated in the treatment of:

skin and soft tissue infections (skinfold pyoderma, impetigo,
folliculitis,
furunculosis, cellulitis) caused by susceptible strains of organisms.

urinary tract infections (UTI) associated or not with prostatitis
caused
by susceptible strains of organisms.

respiratory tract infections caused by susceptible strains of
organisms.
In cats
Marbofloxacin is indicated in the treatment of skin and soft tissue
infections (wounds, abscesses, phlegmons) and upper respiratory tract
infections caused by susceptible strains of organisms.
Revised: September 2023
AN: 00690/2023
Page 2 of 6
4.3
CONTRA-INDICATIONS
Marbofloxacin should not be used in dogs aged less than 12 months, or
less than 18 months for exceptionally large breeds of dogs, such as
Great Danes, Briard, Bernese, Bouvier and Mastiffs, with a longer
growth period. Not recommended for use in cats aged less than 16
weeks.
Do not use in cases of hypersensitivity to fluoroquinolones or any of
the
excipients of the product.
Do not use in cases of resistance against quinolones since (almost)
complete cross-resistance exists against other fluoroquinolones.
Not suitable for infections resulting from strict anaerobes, yeast or
fungi.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Nil
4.5
SPECIAL PRECAUTIONS FOR USE
(I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
The fluoroquinolones have been shown to induce erosion of articular
cartilage in juvenile dogs and care should be taken to dose accurately
especially in young animals.
The fluoroquinolones are also known fo